CSF Biomarkers Measure Tissue Damage Indicative of Disease Activity in Multiple Sclerosis (MS)
A recent study shows that three CSF markers, MBP, NFL and GFAp, can measure ongoing damage of oligodendrocytes, axons and astrocytes in patients with...
New Biomarker Offers Hope for Early Detection of Cardiac Injury
Myocardial infarctions and acute coronary syndrome affect nearly 1 million Americans every year. These events result in damage to the heart tissue and...
Tackling Cancer’s Heterogeneity
This article from GEN suggests tackling cancer's heterogeneity using a multipronged approach that includes current advancements in the detection of pr...
Researchers Identify Signature Protein Biomarkers for Predicting Severity in Flu Cases
Investigators observed samples from 84 naturally influenza-infected individuals and found increased levels of cytokines MCP-3, IFNa2 and plasma IL-10...
A Digest of the Utility of Inflammatory Biomarkers in Major Depression
A comprehensive synopsis from Murdoch University reviews the current state of peripheral inflammatory biomarkers and their potential to improve the tr...
Examining the role inflammatory biomarkers play in an upcoming COPD study
This paper outlines the protocol for a clinical study aimed at determining whether roflumilast (a lon-acting inhibitor of the PDE-4 enzyme) can reduce...
Identifying Prognostic Biomarkers for Amyotrophic Lateral Sclerosis
Using multiplex biomarker analysis, researchers at Penn State University aim to define a panel of prognostic ALS markers. This study shows the most m...